# OraSure receives $18 million hepatitis C test supply contract from unnamed foreign country

OraSure has received an $18 million product supply contract with an unnamed foreign country to support a nationwide hepatitis C testing and treatment program. Deliveries will occur over 12 months through late 2017, with an option to extend through 2018.

- Type: Contract
- Announced: 2016-11-29
- Value: $18.0M
- Status: announced
- Products: OraQuick HCV test
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [OraSure Technologies](https://endata.com/companies/20243.md)

## Sources

- [lvb.com](https://lvb.com/bethlehems-orasure-subsidiary-win-major-contracts/), 2016-11-29: "The international marketplace is becoming an increasingly important opportunity for our business and particularly the OraQuick HCV test."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
